Today: 9 June 2026
Chewy Shares Slip After CEO Cites Stretched Consumer
20 May 2026
2 mins read

Chewy Shares Slip After CEO Cites Stretched Consumer

New York, May 20, 2026, 04:15 EDT

Chewy Inc. shares dropped Tuesday after CEO Sumit Singh said U.S. shoppers are under more financial strain now than at the start of the year. That’s raising fresh concerns about demand for pet supplies.

Chewy ended the session at $19.66, falling 9.1%. The shares touched a low of $19.46 during the day, Google Finance shows. That puts Chewy near its 52-week low, with the stock lagging behind the consumer discretionary sector.

Chewy is due to report Q1 earnings before the open on June 10. The update follows its comments Tuesday, which raised questions around growth in food, medicine, and subscription sales with spending down. Chewy said Monday its results call will start at 8 a.m. ET.

Chewy is “continuing to see and interpret the consumer as being more stretched than we were when we entered the year,” Singh said at the J.P. Morgan Technology, Media & Communications Conference. He said there’s “no shortage of data points” to back that up. Investing.com UK

Consumers are growing more cautious, with early May figures from the University of Michigan putting U.S. consumer sentiment at an all-time low. Higher gasoline costs dragged sentiment down, Reuters reported last week.

Chewy says pet owners keep spending even when other retail slows down. Its Autoship auto-delivery program brought in 83.3% of net sales in fiscal 2025. The company’s annual report shows active customers up 4% to 21.3 million.

J.P. Morgan’s Douglas Anmuth, at the same event, called Chewy the biggest online-only pet retailer in the U.S. He sees net sales coming in around $13.7 billion this year, with about 85% of that from Autoship customers. Anmuth pointed to management’s EBITDA margin goal of 6.7% at the midpoint. EBITDA stands for earnings before interest, taxes, depreciation and amortization.

Chewy has some cushion from broader economic swings, Singh told Barron’s. “The emotive nature of the category, alongside these durable levers that we bring to market, puts us in a category which is relatively much more inert to some of these macro headwinds,” he said. Barron’s

Pet supply stocks saw mixed action after the news. Petco Health and Wellness fell about 2.9%, while BARK surged 7.5%. Amazon, which also sells pet products, lost 2.1%. The Consumer Discretionary Select Sector SPDR ETF declined 1.1%. SPDR S&P 500 ETF was off 0.7%.

Chewy is pushing deeper into pet health, aiming for higher-touch services as product spending stays uncertain. In April, the company announced it will buy Modern Animal, a deal that Chewy said will bring its Vet Care locations from 18 up to 47 and add over $125 million in annualized run-rate revenue. CEO Sumit Singh called Modern Animal a “perfect” fit for Chewy’s push to build a pet health ecosystem. investor.chewy.com

The pet sector’s “defensive” angle runs into problems if buyers start opting for cheaper options, delay purchases, or spend less on services. Food and meds might hold up better than toys or durable goods, but Chewy needs to keep bringing in regular orders, acquiring new customers, and protecting margins. Weak first-quarter results in June would make Tuesday’s decline look more like a reset than a blip.

Citigroup’s Steven Zaccone is sticking with his Buy rating on the stock but trimmed his price target down to $37 from $40 last week. According to Sahm Capital, Zaccone has turned more cautious on retail but still sees upside from where shares finished Tuesday.

Stock Market Today

  • ServiceNow Stock Falls 3.39% Amid Mixed Tech Sector Signals
    June 9, 2026, 10:44 AM EDT. ServiceNow Inc (NOW) opened down 3.39% on June 9, weighed by company-specific factors despite broader tech sector rebounds. The stock declined following its April earnings report, which showed 22% subscription revenue growth and raised guidance but highlighted acquisition costs from Armis that may reduce 2026 margins. Analyst views remain mixed: while many maintain a Buy rating with upside potential, concerns over AI disruption and software spending softness persist. Technical indicators provide a neutral to mixed outlook, with MACD signaling buy but RSI and Williams %R suggesting caution. Broader macroeconomic factors, including strong U.S. jobs data pushing interest rate hike expectations, also pressure tech growth stocks like ServiceNow. The Nasdaq showed selective tech recovery amid recent volatility.

Latest articles

Autozi Shares Jump 400%, Filing Flags Risks for AZI

Autozi Shares Jump 400%, Filing Flags Risks for AZI

9 June 2026
Autozi Internet Technology shares soared over 400% to $5.69 in early Nasdaq trading after a 10-for-1 share consolidation slashed its share count to about 4.49 million, but the surge contrasts with a 63.1% revenue drop, 82.5% plunge in gross profit, and widened net loss, with the company warning of “substantial doubt” about its ability to continue as a going concern.
Redwire Shares Slip After $500 Million Stock Offering Filed

Redwire Shares Slip After $500 Million Stock Offering Filed

9 June 2026
Redwire Corp shares plunged 6.5% to $17.37 after launching a $500 million at-the-market stock program, raising dilution risks for investors as the company seeks flexible funding despite recent record backlog and strong revenue growth; the drop contrasted with gains at other space stocks, highlighting investor concern over potential share issuance.
Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

9 June 2026
Nuvalent shares soared 38.9% to $122.93, just below GSK’s $124-a-share cash offer after the $10.6 billion buyout was announced, as investors bet on the deal closing with Nuvalent’s two lead lung-cancer drugs already under FDA review and a 40% premium to the last closing price driving the morning’s merger-arb trade.
Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
Astera Labs Stock Surges: The AI Networking Bet Traders Are Chasing Before Nvidia Results
Previous Story

Astera Labs Stock Surges: The AI Networking Bet Traders Are Chasing Before Nvidia Results

SpaceX restarts Starlink launches after satellite mishap — and another Falcon 9 is already queued
Next Story

Goldman Said to Get Lead Spot as SpaceX IPO Nears $1.75 Trillion Listing

Go toTop